Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A quick guide helps you compare 401(k) options for your 30s, focusing on fees, employer matches, and potential tax outcomes.
24,750 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
A JPMorgan note argues that a U.S. crypto market structure bill could pass by June and act as a positive catalyst for...
A viral political moment can ripple into your personal finances. This article explains the SAVE Act, why gridlock mat...
Big funds sometimes trim stakes in the market's most valuable names. This article breaks down why institutional inves...
In a volatile market, Hyperliquid is turning heads with its HYPE token and HIP-3 pre-IPO perps. This piece breaks dow...
A new wave of government-backed AI infrastructure could unlock enormous opportunities for investors. This guide expla...
A broad pullback in semiconductors gave way to a cautious rally for Sandisk. This article breaks down what sparked th...
Across major firms, AI agents now outnumber human staff in many back offices and customer channels. Leaders outline g...
A major shakeup in AI deals spotlights coding as a premier use case for generative AI. Google hires Windsurf talent a...
Celebrity branding can turn a sip into serious money. This article dives into Olivia Attwood’s Savano cocktail and wh...
The Pentagon unveiled sweeping new rules governing Stars and Stripes, the military newspaper, tightening editorial ov...
A wave of AI-driven disruption arrived years early—now forcing employers and households to rethink careers, savings, ...